JUBILANT PHARMOVA
Back to Income Statement
|
JUBILANT PHARMOVA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹7,235 Cr | ₹6,703 Cr | ₹6,282 Cr | ₹6,130 Cr | ₹6,099 Cr |
What is the latest Revenue of JUBILANT PHARMOVA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹7,235 Cr |
| Mar2024 | ₹6,703 Cr |
| Mar2023 | ₹6,282 Cr |
| Mar2022 | ₹6,130 Cr |
| Mar2021 | ₹6,099 Cr |
How is Revenue of JUBILANT PHARMOVA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,235 Cr | 7.93 | |
| Mar2024 | ₹6,703 Cr | 6.71 | |
| Mar2023 | ₹6,282 Cr | 2.47 | |
| Mar2022 | ₹6,130 Cr | 0.52 | |
| Mar2021 | ₹6,099 Cr | - | |
Compare Revenue of peers of JUBILANT PHARMOVA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JUBILANT PHARMOVA | ₹17,313.5 Cr | -0.1% | 0.6% | -3.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
JUBILANT PHARMOVA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JUBILANT PHARMOVA | -0.1% |
0.6% |
-3.6% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses